Invest now

Epigral share price

Balanced risk
  • 44%Low risk
  • 44%Moderate risk
  • 44%Balanced risk
  • 44%High risk
  • 44%Extreme risk
  • 1,105.00(0.72%)
    August 7, 2026 15:29:28 PM IST
    • NSE
    • BSE
  • Vol : 18.97 K (NSE + BSE)
    Last 20 day avg : 164.54 K
Epigral is trading 0.72% upper at Rs 1,105.00 as compared to its last closing price. Epigral has been trading in the price range of 1,110.50 & 1,094.75. Epigral has given -10.19% in this year & -0.86% in the last 5 days. Epigral has TTM P/E ratio 17.26 as compared to the sector P/E of 28.62.There are 1 analysts who have initiated coverage on Epigral. There are 1 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 99.74 Crores in its last quarter.Listed peers of Epigral include Asian Paints (-1.02%), Solar Industries India (-0.86%), Pidilite Industries (-0.54%).The Mutual Fund holding in Epigral was at 5.52% in 30 Jun 2026. The MF holding has increased from the last quarter. The FII holding in Epigral was at 1.03% in 30 Jun 2026. The FII holding has decreased from the last quarter.
  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Loading...
Key Metrics

Updated on 09 Aug 2026, 08:00 PM IST

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.70
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.26
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.46
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -5.33
    Indicates undervaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
Price range
Day Range
Lowest
1,094.75
Highest
1,110.50
52 week range
Lowest
806.20
Highest
1,946.05
Epigral Peers
Return Comparison
Peers Comparison
Names
Price%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Asian Paints
2,721.00-1.022,60,997.7258.0912.061.0211.95
Solar Industries India
18,400.00-0.861,66,501.7099.6126.620.0613.68
Pidilite Industries
1,662.00-0.541,69,156.7664.7614.710.732.03
SRF
2,616.50-0.3677,559.5644.576.070.3114.26
Linde India
7,085.00-0.7660,717.27110.5314.220.061.76
Mutual Fund Ownership
View all
HSBC Focused Fund Regular Growth
3/5
  • Amount Invested (Cr.) 44.62
  • % of AUM 2.68
HSBC Business Cycles Regular Growth
NA
  • Amount Invested (Cr.) 13.60
  • % of AUM 1.26
ITI Small Cap Fund Regular Growth
3/5
  • Amount Invested (Cr.) 25.90
  • % of AUM 1.03
ITI Multi Cap Fund Regular Growth
2/5
  • Amount Invested (Cr.) 12.67
  • % of AUM 1.01
Bandhan Business Cycle Fund Regular Growth
NA
  • Amount Invested (Cr.) 17.01
  • % of AUM 1.01
Epigral Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-07-27Quarterly Results
2026-05-02Audited Results & Final Dividend
2026-01-30Quarterly Results
2025-11-10Quarterly Results
2025-08-02Quarterly Results & Fund Raising
About the company Epigral
  • IndustryChemical Manufacturing
  • ISININE071N01016
  • BSE Code543332
  • NSE CodeEPIGRAL
Epigral Limited is an India-based manufacturer of essential chemicals. The Company is engaged in the manufacturing and selling of chemicals, including derivatives and specialty chemicals. It operates under two businesses, Chlor-Alkali and Derivatives and Speciality chemicals, which relate to the manufacturing of Chlor-Alkali & its Derivatives. Chlor-Alkali is an industrial process that offers Sodium Hypochlorite, Hydrogen Gas, Caustic Soda Lye, Caustic Soda Flakes, and Liquid Chlorine. The Company offers a diverse portfolio of products, including chlorinated polyvinyl chloride (CPVC) Resin, CPVC Compound, Chlorotoluenes Value Chain, Epichlorohydrin, Chloromethanes, Hydrogen Peroxide, Caustic Soda, Chlorine, Hydrogen, and Caustic Potash. The Company caters to a range of industries such as refineries, paper and pulp, fluoropolymers, soaps & detergents, textiles, dyes & pigment, pharmaceuticals, agrochemicals, paints and coating, refrigerant gas, electronics, water treatment, and others.
  • Management Info
  • Maulik PatelChairman of the Board, Managing Director
  • Rakesh AgrawalChief Financial Officer
  • Gaurang TrivediCompliance Officer, Company Secretary
  • Kaushal SoparkarExecutive Director
Epigral Share Price FAQs

Epigral is trading at 1105.00 as on Fri Aug 07 2026 09:59:28. This is 0.72% upper as compared to its previous closing price of 1097.15.

The market capitalization of Epigral is 4798.17 Cr as on Fri Aug 07 2026 09:59:28.

The average broker rating on Epigral is Strong Buy. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 0.00 analysts have given a buy rating
  • 0.00 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Epigral is 1946.05 whereas the 52 wk low is 806.20

Epigral can be analyzed on the following key metrics -

  • TTM P/E: 17.26
  • Sector P/E: 28.62
  • Dividend Yield: 0.46%
  • D/E ratio: -

Epigral reported a net profit of 331.97 Cr in 2026.

The Mutual Fund Shareholding was 5.52% at the end of 30 Jun 2026.